(Q37582800)

21 August 2017

1 reference

title

Secondary prevention strategies for coronary heart disease (English)

1 reference

21 August 2017

Shepard D Weiner

1

1 reference

PubMed ID

19693440

21 August 2017

LeRoy E Rabbani

series ordinal

2

1 reference

21 August 2017

1 January 2010

1 reference

Journal of Thrombosis and Thrombolysis

21 August 2017

1 reference

21 August 2017

29

1 reference

21 August 2017

1

1 reference

21 August 2017

8-24

1 reference

https://scigraph.springernature.com/pub.10.1007/s11239-009-0381-8

21 August 2017

0 references

cites work

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Natural history and histological classification of atherosclerotic lesions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Association of influenza vaccination and reduced risk of recurrent myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Obesity: impact of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Smoking status and risk for recurrent coronary events after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

An overview of randomized trials of rehabilitation with exercise after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0381-8

Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Ph

21 January 2018

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

12 December 2020

Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS).

1 reference

12 December 2020

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

12 December 2020

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

1 reference

12 December 2020

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease

1 reference

12 December 2020

Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis

1 reference

12 December 2020

Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study

1 reference

12 December 2020

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

1 reference

12 December 2020

SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts

1 reference

12 December 2020

Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP.

1 reference

12 December 2020

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

1 reference

12 December 2020

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease

1 reference

12 December 2020

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui

1 reference

12 December 2020

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

12 December 2020

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

1 reference

12 December 2020

Atherothrombosis and high-risk plaque: part I: evolving concepts

1 reference

12 December 2020

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

1 reference

12 December 2020

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

1 reference

12 December 2020

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

12 December 2020

Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

1 reference

12 December 2020

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

12 December 2020

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

1 reference

12 December 2020

Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention

1 reference

12 December 2020

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

12 December 2020

Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Clopidogrel, genetics, and drug responsiveness

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

12 December 2020

Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure

1 reference

12 December 2020

Effects of torcetrapib in patients at high risk for coronary events

1 reference

12 December 2020

Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise

1 reference

12 December 2020

Pathophysiology of coronary artery disease

1 reference

12 December 2020

Simon Dack Lecture. The genomic basis of myocardial infarction.

1 reference

12 December 2020

Obesity : impact on cardiovascular disease

1 reference

12 December 2020

Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials

1 reference

12 December 2020

Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications

1 reference

12 December 2020

Depression and Coronary Heart Disease

1 reference

12 December 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients

1 reference

12 December 2020

Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes

1 reference

12 December 2020

Clinical overview of promising nonthienopyridine antiplatelet agents

1 reference

12 December 2020

Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome

1 reference

12 December 2020

Protease-activated receptors in cardiovascular health and diseases

1 reference

12 December 2020

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

1 reference

12 December 2020

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

12 December 2020

Heart rate and arterial blood pressure during exercise in patients with angina pectoris. Effects of training and of nitroglycerin

1 reference

12 December 2020

Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease

1 reference

12 December 2020

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

12 December 2020

Angiographic progression of coronary artery disease and the development of myocardial infarction

1 reference

12 December 2020

Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups

1 reference

12 December 2020

Closed contour edge detection of blood vessel lumen and outer wall boundaries in black-blood MR images.

1 reference

12 December 2020

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

12 December 2020

Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives

1 reference

12 December 2020

Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study

1 reference

12 December 2020

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

12 December 2020

Protease-activated receptors in cardiovascular diseases

1 reference

12 December 2020

Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Coun

1 reference

12 December 2020

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

12 December 2020

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

12 December 2020

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

1 reference

12 December 2020

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

12 December 2020

Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography

1 reference

12 December 2020

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

1 reference

12 December 2020

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

1 reference

12 December 2020

Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy.

1 reference

12 December 2020

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

12 December 2020

Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02.

1 reference

12 December 2020

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

12 December 2020

Warfarin, aspirin, or both after myocardial infarction

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Resistance to clopidogrel: a review of the evidence

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infar

1 reference

12 December 2020

What Genome-wide Association Studies Can Do for Medicine

1 reference

12 December 2020

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

12 December 2020

Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization

1 reference

12 December 2020

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

1 reference

12 December 2020

Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching

1 reference

12 December 2020

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

1 reference

12 December 2020

Illuminating HDL--is it still a viable therapeutic target?

1 reference

12 December 2020

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

12 December 2020

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

1 reference

12 December 2020

Stent thrombosis in randomized clinical trials of drug-eluting stents

1 reference

12 December 2020

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

12 December 2020

C-reactive protein predicts death in patients with previous premature myocardial infarction--a 10 year follow-up study

1 reference

12 December 2020

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Tracking progression of heart disease with cardiac computed tomography

1 reference

12 December 2020

Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

12 December 2020

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates

1 reference

12 December 2020

Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials

1 reference

12 December 2020

Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial

1 reference

12 December 2020

B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study

1 reference

12 December 2020

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

12 December 2020

Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms

1 reference

12 December 2020

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study

1 reference

12 December 2020

Cardiac effects of prolonged and intense exercise training in patients with coronary artery disease

1 reference

12 December 2020

Cardiac rehabilitation after myocardial infarction in the community

1 reference

12 December 2020

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

12 December 2020

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

1 reference

12 December 2020

Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria

1 reference

12 December 2020

Durability of platelet inhibition by clopidogrel

1 reference

12 December 2020

Exercise-based rehabilitation for coronary heart disease

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

1 reference

12 December 2020

Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association

1 reference

12 December 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

12 December 2020

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Genomewide association analysis of coronary artery disease

1 reference

12 December 2020

Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events

1 reference

12 December 2020

Recommendations for the management of patients after heart valve surgery

1 reference

12 December 2020

Novel antiplatelet strategies in acute coronary syndromes

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design

1 reference

12 December 2020

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in coll

1 reference

12 December 2020

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

1 reference

12 December 2020

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

1 reference

12 December 2020

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

12 December 2020

Can the polypill save the world from heart disease?

1 reference

12 December 2020

Impact of high-normal blood pressure on the risk of cardiovascular disease

1 reference

12 December 2020

Platelet function testing in cardiovascular diseases

1 reference

12 December 2020

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range

1 reference

12 December 2020

Intensifying platelet inhibition--navigating between Scylla and Charybdis

1 reference

12 December 2020

Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease

1 reference

12 December 2020

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

12 December 2020

Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.

1 reference

12 December 2020

Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population

1 reference

12 December 2020

Atherosclerosis: the path from genomics to therapeutics

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists

1 reference

12 December 2020

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

1 reference

12 December 2020

Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review

1 reference

12 December 2020

Core components of cardiac rehabilitation/secondary prevention programs: A statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing Group

1 reference

12 December 2020

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques

1 reference

12 December 2020

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

12 December 2020

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

12 December 2020

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

1 reference

12 December 2020

Statin-associated myopathy

1 reference

12 December 2020

Azithromycin for the secondary prevention of coronary events

1 reference

12 December 2020

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

12 December 2020

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

12 December 2020

Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis

1 reference

12 December 2020

Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease

1 reference

12 December 2020

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

1 reference

12 December 2020

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

12 December 2020

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.

1 reference

12 December 2020

Optimal medical therapy with or without PCI for stable coronary disease

1 reference

12 December 2020

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

12 December 2020

B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next?

1 reference

12 December 2020

Beyond unfractionated heparin and warfarin: current and future advances

1 reference

12 December 2020

Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

12 December 2020

Vitamin D deficiency and risk of cardiovascular disease

1 reference

12 December 2020

Oral anticoagulants in patients with coronary artery disease

1 reference

12 December 2020

10.1007/S11239-009-0381-8

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19693440